Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties

Breast cancer is the most common cancer diagnosis in women worldwide, with approximately 1.7 million new cases diagnosed in 2012, equivalent to about 12% of all new cancer cases and 25% of all cancers in women [1]. In the developed countries the total number of survivors at 5  years was about 3.2 million women [1]. Survival rates have improved in recent years partly due to diagnosis at an earlier and localized stage, which is the result of planed mammography screening for women of age above 40 years, and partly due to improved treatment methods (surgery, hormone/chemo therapy, radiotherapy) and follow-up examinations.
Source: Physica Medica: European Journal of Medical Physics - Category: General Medicine Authors: Tags: Original paper Source Type: research